• Login
    Search 
    •   UBIR Home
    • Search
    •   UBIR Home
    • Search
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Search

    Show Advanced FiltersHide Advanced Filters

    Filters

    Use filters to refine the search results.

    Now showing items 1-10 of 19

    • Sort Options:
    • Relevance
    • Title Asc
    • Title Desc
    • Issue Date Asc
    • Issue Date Desc
    • Results Per Page:
    • 5
    • 10
    • 20
    • 40
    • 60
    • 80
    • 100
    Thumbnail

    Investigation of Inter-Individual Variability in Monoclonal Antibody Disposition 

    Thomas, Veena; 0000-0002-5202-6697 (State University of New York at Buffalo, 2018)
    Substantial inter-individual variability (IIV) in monoclonal antibody (mAb) pharmacokinetics has been reported in the clinic. The sources of variability are not well understood and often not explored. Very few preclinical ...
    Thumbnail

    Machine Learning and Network-Based Systems Toxicology Modeling of Chemotherapy-Induced Peripheral Neuropathy 

    Bloomingdale, Peter (State University of New York at Buffalo, 2018)
    The overarching goal of my thesis work was to utilize the combination of mathematical and experimental models towards an effort to resolve chemotherapy-induced peripheral neuropathy (CIPN), one of the most common adverse ...
    Thumbnail

    Optimized Engineering Platform for the Generation of Recycling Therapeutic Antibodies 

    Kroetsch, Andrew (State University of New York at Buffalo, 2019)
    A new modality in antibody engineering has emerged in which the antigen affinity is designed to be pH dependent (PHD). In particular, the combination of high affinity binding at neutral pH with low affinity binding at ...
    Thumbnail

    Challenges Facing the Subcutaneous Administration of Therapeutic Monoclonal Antibodies 

    Turner, Michael (State University of New York at Buffalo, 2019)
    As an ever increasing number of therapeutic antibodies are being formulated and designed for subcutaneous (SC) dosing, it is an ever growing importance to understand the complexities of this route of administration. The ...
    Thumbnail

    Megalin, Cubilin, and FcRn Expression in Type 2 Diabetes: Implications for Pharmaceutics and Diabetic Kidney Disease 

    Bryniarski, Mark (State University of New York at Buffalo, 2019)
    Monoclonal antibodies (mAbs) continue to lead protein therapeutics. However, very few studies have examined the impact of diabetes mellitus (DM), one of the most frequent disease states worldwide, on mAb disposition. ...
    Thumbnail

    Toxicodynamic and Toxicokinetic Based Treatment of γ-Hydroxybutyric Acid (GHB) Overdose 

    Follman, Kristin (State University of New York at Buffalo, 2019)
    γ-Hydroxybutyric acid (GHB) is a short chain fatty acid which was first discovered through its synthesis in 1874, and later found to be an endogenous compound in the human central nervous system. GHB is a structural analogue ...
    Thumbnail

    Deorphanizing Monocarboxylate Transporter 6: Evidence of Functional Roles in Lipid Metabolism and Drug Transport 

    Jones, Robert (State University of New York at Buffalo, 2019)
    Monocarboxylate transporters (MCTs) are members of the solute carrier 16 (SLC16) family of transporter proteins that are responsible for wide range of essential physiological processes. In total, there are fourteen isoforms ...
    Thumbnail

    Pharmacokinetics and Receptor-Mediated Pharmacodynamics of Methylprednisolone 

    Ayyar, Vivaswath (State University of New York at Buffalo, 2019)
    The corticosteroids possess substantial anti-inflammatory and immunomodulatory activity. Prolonged use of these drugs are, however, associated with adrenal suppression and other dose-limiting metabolic toxicities, manifested ...
    Thumbnail

    Pharmacokinetics-Pharmacodynamics Based Investigations to Support the Development of Antibody-Drug Conjugates 

    Singh, Aman (State University of New York at Buffalo, 2019)
    Antibody-drug Conjugates (ADCs) are one of the fastest growing class of anticancer therapeutics, which consists of monoclonal antibodies (mAbs) covalently bound to highly potent chemotherapeutic agents (payloads) via ...
    Thumbnail

    Engineered Antibody Fragments Targeting Chemokine Receptors to Modulate Macrophage Phenotype for Tumor Inhibition 

    Deci, Michael; 0000-0003-1249-6616 (State University of New York at Buffalo, 2019)
    In Chapter I we give a perspective and comprehensive review on design principles of targeted nanocarriers with an emphasis on improving clinical translation. We discuss membrane fluidity and spatial control of ligand ...
    • 1
    • 2

    To add content to the repository or for technical support: Contact Us
     

     

    Browse

    All of UBIRCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsTypes

    My Account

    LoginRegister

    Discover

    Author0000-0001-7676-6473 (1)0000-0002-2703-1590 (1)0000-0002-5202-6697 (1)0000-0003-0244-8856 (1)0000-0003-1249-6616 (1)Andrews, Kayla (1)Ayyar, Vivaswath (1)Bloomingdale, Peter (1)Bryniarski, Mark (1)Deci, Michael (1)... View MoreSubject
    Pharmaceutical sciences (19)
    Pharmacology (3)Bioengineering (1)Chemical engineering (1)Chemistry (1)Immunology (1)Neurosciences (1)Organic chemistry (1)Physiology (1)Systems science (1)... View MoreType
    Dissertation (19)
    Text (18)... View MoreDate Issued2019 (11)2018 (8)

    To add content to the repository or for technical support: Contact Us